NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) — In connection with Japan Smaller Capitalization Fund, Inc. (the “Fund”) (NYSE: JOF)’s previously announced conditional tender offer, the Fund today announced that its Board of Directors (the “Board”) has approved a tender offer (the “Tender Offer”) to purchase up to 10% of its issued and outstanding shares at a price per share equal to 98% of the net asset value (“NAV”) per share as of the pricing date. The Tender Offer is expected to commence on June 1, 2026, and expire at 5:00 p.m. on July 1, 2026 (the “Expiration Date”), with a pricing date of July 2, 2026, unless extended. If more shares are tendered than the maximum amount specified in the offer, the Fund intends to purchase shares from tendering shareholders on a pro rata basis, based on the number of shares tendered by each shareholder. The...

Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European launch expected in Germany in Q3 2026 Approval adds to Joenja® approvals in the United States, United Kingdom, Japan, Australia and Israel, supporting Pharming’s global expansion strategyLeiden, the Netherlands, May 22, 2026: Pharming Group (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced that the European Commission (EC) has granted marketing authorization for Joenja® (leniolisib), an oral, selective phosphoinositide 3-kinase (PI3K) delta inhibitor, for the treatment of activated PI3K delta syndrome (APDS), a rare primary immunodeficiency, in adult and...

TORONTO, May 22, 2026 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) set August 18, 2026, for its annual general and special meeting (“AGM”), when it will also fulfil the requisition of Waratah Capital Advisors Ltd. (“Waratah”) for a shareholder meeting to address board renewal. On recommendation of Lithium Ionic’s special committee, the board of the Company has called the shareholder meeting to address typical annual matters, including the election of members of the board of directors for the ensuing year. The Company anticipates continued discussion with representatives of Waratah and other shareholders to identify further directors for nomination. Shareholders will be aware that certain directors have ceased to be members of the Company’s board of directors and have...

BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 Brøndby, den 22. maj 2026 SELSKABSMEDDELELSE NR. 4/2026Brøndby IF ansætter Julius Ohnesorge som fodbolddirektør og ophæver samarbejdet med Steve Cooper og Alan Tate Brøndby IF har i dag indgået en aftale med Julius Ohnesorge, der tiltræder i rollen som fodbolddirektør dags dato. Brøndby IF har endvidere i dag ophævet samarbejdet med cheftræner Steve Cooper og assistenttræner Alan Tate med øjeblikkelig virkning. Brøndby IFBestyrelsenInformationYderligere information om denne meddelelse kan fås hos kommunikationsdirektør Søren Hanghøj på 25 45 68 68.AttachmentFBM nr 4 2026 Brøndby IF

Agreement covers 6,000 airport and customer service employees MONTREAL, May 22, 2026 (GLOBE NEWSWIRE) — Air Canada today said it has reached a tentative collective agreement with Unifor, representing approximately 6,000 contact centre, customer relations, concierge, airport in-terminal and customer journey management employees at Air Canada. The tentative agreement recognizes the contributions and professionalism of Air Canada’s frontline airport and customer service agents, while providing a framework for the future growth of the airline. Terms of the new agreement will remain confidential pending a ratification vote by the membership, expected to be completed over the next month, and approval by the Air Canada Board of Directors. About Air Canada Air Canada is Canada’s largest airline, the country’s flag carrier...

REV Corporate Video: https://youtu.be/biOHmBtI8ns VANCOUVER, British Columbia, May 22, 2026 (GLOBE NEWSWIRE) — REV Exploration Corp. (“REV” or the “Company”) (TSXV: REVX; OTC: REVFF; FSE: 7FF) is pleased to announce that, further to its February 19, 2026 news release, it has closed the disposition of certain mining claims held by the Company in Quebec (the “Purchased Assets”) (the “Transaction”), pursuant to an asset purchase agreement between the Company and Major Gold Corp. (“MGC”) dated February 19, 2026 (the “Asset Purchase Agreement”) for a purchase price of $1,240,000 of share consideration (the “Purchase Price”). Commenting on the Transaction, Jordan Potts, CEO and Director of REV, stated: “REV is pleased to complete this transaction with Major Gold, which we believe provides a pathway for these assets to continue to be...

Leo International Precision Health AG / Keyword: Capital measures / Capital increase Leo International Precision Health AG approves cash capital increase excluding subscription rights 22. May 2026 / 20:04 CET/CESTDisclosure of an inside information acc. to Article 17 of the Regulation (EU) No 596/2014, transmitted by GlobeNewswire.The issuer is solely responsible for the content of this announcement.The management board and the supervisory board of Leo International Precision Health AG (ISIN DE0005490601, WKN 549060, ticker symbol LEOW, „Company“) resolved today to increase the Company’s share capital by approximately 4.2 % against cash contributions through the issuance of 24,000 new no-par bearer shares of the Company (“New Shares”), utilizing a portion of the authorized capital 2025 and excluding shareholders’ subscription...